Literature DB >> 10377390

Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli.

H I Zgurskaya1, H Nikaido.   

Abstract

AcrAB is a constitutively expressed, major multidrug efflux system of Escherichia coli. We have purified the cytoplasmic membrane component, AcrB, to near homogeneity, and reconstituted the protein into proteoliposomes. In the presence of DeltapH (outside acid), the protein catalyzed the extrusion of fluorescent phospholipids, which were then trapped by protein-free acceptor vesicles. Known substrates of AcrAB, such as bile acids, erythromycin, and cloxacillin, inhibited this activity. Addition of various drugs to AcrB-containing proteoliposomes, in the presence of DeltapH (inside acid) resulted in proton efflux, suggesting that AcrB is a proton antiporter. Interestingly, fluorescent lipid extrusion was accelerated strongly by the periplasmic protein AcrA in the presence of Mg2+, and at pH 5.0 AcrA alone produced a slow mixing of lipids of different vesicles, without causing the mixing of intravesicular material. These results suggest that AcrA brings two membranes together, and under certain conditions may even cause the fusion of at least the outer leaflets of the membranes, contributing to the ability of the AcrAB-TolC system to pump drugs out directly into the medium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377390      PMCID: PMC22048          DOI: 10.1073/pnas.96.13.7190

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A rapid, sensitive, and specific method for the determination of protein in dilute solution.

Authors:  W Schaffner; C Weissmann
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

Review 2.  A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gram-negative bacteria.

Authors:  T Dinh; I T Paulsen; M H Saier
Journal:  J Bacteriol       Date:  1994-07       Impact factor: 3.490

3.  Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport.

Authors:  M H Saier; R Tam; A Reizer; J Reizer
Journal:  Mol Microbiol       Date:  1994-03       Impact factor: 3.501

4.  pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact.

Authors:  H Ellens; J Bentz; F C Szoka
Journal:  Biochemistry       Date:  1984-03-27       Impact factor: 3.162

5.  Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles.

Authors:  L D Mayer; M J Hope; P R Cullis; A S Janoff
Journal:  Biochim Biophys Acta       Date:  1985-07-11

6.  Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion.

Authors:  G W Kemble; T Danieli; J M White
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

7.  Electrogenic H+ translocation by the plasma membrane ATPase of Neurospora. Studies on plasma membrane vesicles and reconstituted enzyme.

Authors:  D S Perlin; K Kasamo; R J Brooker; C W Slayman
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

8.  Use of resonance energy transfer to monitor membrane fusion.

Authors:  D K Struck; D Hoekstra; R E Pagano
Journal:  Biochemistry       Date:  1981-07-07       Impact factor: 3.162

9.  Phosphatidylcholine translocase: a physiological role for the mdr2 gene.

Authors:  S Ruetz; P Gros
Journal:  Cell       Date:  1994-07-01       Impact factor: 41.582

10.  Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin.

Authors:  X Z Li; D M Livermore; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

View more
  153 in total

1.  Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams.

Authors:  A Mazzariol; G Cornaglia; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 2.  A functional-phylogenetic classification system for transmembrane solute transporters.

Authors:  M H Saier
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

3.  High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.

Authors:  A Mazzariol; Y Tokue; T M Kanegawa; G Cornaglia; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 4.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

5.  Cross-linked complex between oligomeric periplasmic lipoprotein AcrA and the inner-membrane-associated multidrug efflux pump AcrB from Escherichia coli.

Authors:  H I Zgurskaya; H Nikaido
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

Review 6.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Coarse-grained simulations of conformational changes in the multidrug efflux transporter AcrB.

Authors:  Yead Jewel; Jin Liu; Prashanta Dutta
Journal:  Mol Biosyst       Date:  2017-09-26

8.  The effects of micronutrient deficiencies on bacterial species from the human gut microbiota.

Authors:  Matthew C Hibberd; Meng Wu; Dmitry A Rodionov; Xiaoqing Li; Jiye Cheng; Nicholas W Griffin; Michael J Barratt; Richard J Giannone; Robert L Hettich; Andrei L Osterman; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

Review 9.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli.

Authors:  Julio Ramos Aires; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.